Blue Trust’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$824 Hold
284
– – ﹤0.01% 2201
2026
Q2
$1.33K Hold
284
– – ﹤0.01% 2252
2026
Q1
$1.17K Hold
284
– – ﹤0.01% 2233
2025
Q4
$1.14K Hold
284
– – ﹤0.01% 2263
2025
Q3
$971 Hold
284
– – ﹤0.01% 2328
2025
Q2
$540 Hold
284
– – ﹤0.01% 2311
2025
Q1
$2.01K Hold
284
– – ﹤0.01% 2222
2024
Q4
$6.25K Hold
284
– – ﹤0.01% 2050
2024
Q3
$4.94K Hold
284
– – ﹤0.01% 2404
2024
Q2
$11.8K Hold
284
– – ﹤0.01% 1868
2024
Q1
$11.8K Hold
284
– – ﹤0.01% 1398
2023
Q4
$9K Hold
284
– – ﹤0.01% 1636
2023
Q3
$17K Hold
284
– – ﹤0.01% 1235
2023
Q2
$7K Hold
284
– – ﹤0.01% 1442
2023
Q1
$8K Hold
284
– – ﹤0.01% 1673
2022
Q4
$15K Hold
284
– – ﹤0.01% 1410
2022
Q3
$8K Hold
284
– – ﹤0.01% 1447
2022
Q2
$15K Buy
+284
New +$10.8K ﹤0.01% 1078

Other funds holding XFOR

Blue Trust's XFOR Position: Q3 2026 in Review

Blue Trust held its X4 Pharmaceuticals (XFOR) position steady in Q3 2026 at 284 shares worth $824. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Blue Trust first reported a position in XFOR in Q2 2022 and has held it in 18 quarters since. The position peaked at $17K in Q3 2023. 59 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.

  • Blue Trust held 284 shares of X4 Pharmaceuticals worth $824 as of Q3 2026.
  • Blue Trust left its X4 Pharmaceuticals share count unchanged in Q3 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2201 holding.
  • Blue Trust first reported a position in X4 Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's X4 Pharmaceuticals position peaked at $17K in Q3 2023.
  • 59 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.